Journal article icon

Journal article

Treatment of breast and prostate cancer by hypofractionated radiotherapy: potential risks and benefits

Abstract:

Breast cancer and prostate cancer are the most common cancers diagnosed in women and men, respectively, in the UK, and radiotherapy is used extensively in the treatment of both. In vitro data suggest that tumours in the breast and prostate have unique properties that make a hypofractionated radiotherapy treatment schedule advantageous in terms of therapeutic index. Many clinical trials of hypofractionated radiotherapy treatment schedules have been completed to establish the extent to which hy...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.clon.2015.02.008

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Sub department:
CRUK/MRC Ox Inst for Radiation Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
More from this funder
Funding agency for:
Ray, K
Grant:
MC_ST_U13080
More from this funder
Funding agency for:
Sibson, N
Grant:
C5255/A15935
More from this funder
Funding agency for:
Kiltie, A
Grant:
C5255/A15935
Publisher:
Elsevier Publisher's website
Journal:
Clinical oncology (Royal College of Radiologists (Great Britain)) Journal website
Volume:
27
Issue:
7
Pages:
420-426
Publication date:
2015-07-01
DOI:
EISSN:
1433-2981
ISSN:
0936-6555
Source identifiers:
512981
Language:
English
Keywords:
Pubs id:
pubs:512981
UUID:
uuid:c46f546c-b62f-4369-8ce0-1f89213f6a7c
Local pid:
pubs:512981
Deposit date:
2015-11-20

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP